
Uribegro S 25mg/5mg Tablet ER
Marketer
Tas Med India Pvt Ltd
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Uribegro S 25mg/5mg Tablet ER
Uribegro S 25mg/5mg Extended-Release tablets combine two medications to manage overactive bladder symptoms. This treatment addresses urinary frequency, urgency, and incontinence. Follow your doctor's instructions precisely regarding dosage and treatment length. Uribegro S may be taken with or without food, ideally at the same time daily. Discontinuing the medication prematurely, without medical consultation, may exacerbate symptoms. Complete the prescribed course for optimal results. Common side effects include elevated blood pressure, upper respiratory infection (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or bothersome side effects promptly to your physician. Before starting treatment, disclose all other medications and pre-existing health conditions. Pregnant or breastfeeding individuals should inform their doctor. Patients with liver or kidney impairment require careful monitoring and regular check-ups as directed by their healthcare provider.
Primary Ingredients of Uribegro S 25mg/5mg Tablet ER
No text was provided to rewrite.
Uses of Uribegro S 25mg/5mg Tablet ER
Symptoms of an overactive urinary bladder
Major Benefits of Uribegro S 25mg/5mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Uribegro S 25mg/5mg Extended-Release Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Uribegro S 25mg/5mg Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Uribegro S 25mg/5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Uribegro S 25mg/5mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. While it can be consumed with or without food, consistent daily timing is recommended.
How Uribegro S 25mg/5mg Tablet ER works:
Uribegro S 25mg/5mg Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves similar relaxation of the bladder musculature through a different mechanism. This dual action reduces the frequency, urgency, and involuntary urges to urinate.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcoholic beverages and Uribegro S 25mg/5mg Extended-Release Tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Uribegro S 25mg/5mg Extended-Release Tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Uribegro S 25mg/5mg Extended-Release tablets while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Uribegro S 25mg/5mg Tablet ER on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Uribegro S 25mg/5mg Extended-Release Tablets in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Uribegro S 25mg/5mg Extended-Release Tablets in individuals with hepatic impairment. Seek medical advice.
What if you forget to take Uribegro S 25mg/5mg Tablet ER :
NA
Facts to Know About Uribegro S 25mg/5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urologic Care |
